Ning Jin
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
- Oncology 18
- Cancer Immunotherapy and Biomarkers 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Douglas W. Ball (7 shared papers)Barry D. Nelkin (7 shared papers)Tianyun Jiang (4 shared papers)Laith Abushahin (4 shared papers)Adithya Chennamadhavuni (1 shared paper)Ashish Manne (1 shared paper)Carolyn J. Presley (1 shared paper)Brendan Collins (2 shared papers)
- Journals
- Cancers (4 papers)Journal of Clinical Oncology (4 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ning Jin
59 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 645
- Cancer Research 175
- Molecular Biology 636
- Endocrinology, Diabetes and Metabolism 145
- Epidemiology 256
Countries citing papers authored by Ning Jin
This map shows the geographic impact of Ning Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Jin more than expected).
Fields of papers citing papers by Ning Jin
This network shows the impact of papers produced by Ning Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Jin. The network helps show where Ning Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors Hit paper breakdown → | 2022 | 202 |
| 2 | 2009 | 149 | |
| 3 | 2005 | 97 | |
| 4 | 2021 | 87 | |
| 5 | 2007 | 79 | |
| 6 | 2011 | 75 | |
| 7 | 2009 | 66 | |
| 8 | 2005 | 59 | |
| 9 | 2020 | 56 | |
| 10 | 2016 | 36 | |
| 11 | 2022 | 36 | |
| 12 | 2021 | 35 | |
| 13 | 2005 | 32 | |
| 14 | 2021 | 30 | |
| 15 | 2001 | 30 | |
| 16 | 2022 | 23 | |
| 17 | 2023 | 19 | |
| 18 | 2015 | 19 | |
| 19 | 2016 | 19 | |
| 20 | 2020 | 18 |
About Ning Jin
Ning Jin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 66 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Epigenetics and DNA Methylation (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Oncology (645 citations), Cancer Research (175 citations), Molecular Biology (636 citations), Endocrinology, Diabetes and Metabolism (145 citations) and Epidemiology (256 citations). Ning Jin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Douglas W. Ball, Barry D. Nelkin, Tianyun Jiang, Laith Abushahin, Adithya Chennamadhavuni, Ashish Manne, Carolyn J. Presley, Brendan Collins, Dina Rosen and D. Neil Watkins. Their work appears in journals such as Cancers, Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism, Frontiers in Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.